Session Information
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer in Singapore
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
All times listed are in Singapore time (GMT+8)
PL - Plenary
PS - Presidential Symposium
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
IS - Industry Symposium
JICC - Joint IASLC-CAALC-CSCO Session
January 28 Thu
Jan 28 Friday
January 29 Fri
Jan 29 Saturday
January 30 Sat
Jan 30 Sunday
January 31 Sun
Jan 31
-
+
P05 - Early Stage/Localized Disease - Radiotherapy
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Early Stage/Localized Disease
-
+
P05.04 - Association of Lymphopenia and Disease Progression in Unresectable NSCLC Treated with Definitive Chemoradiation and Immunotherapy
00:00 - 00:00 | Presenter: Cole Friedes
- Abstract
Loading...
-
+
P21 - Locoregional and Oligometastatic Disease - Treatment of Locally Advanced NSCLC
- 00:00 - 00:00
- 1/28/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Locoregional and Oligometastatic Disease
-
+
P21.04 - Comparing Outcomes for Patients Receiving Chemoradiation Followed by Surgery vs. Immune Checkpoint Inhibitors in Non Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Turja Chakrabarti
- Abstract
Loading...
-
+
IS10 - Industry Symposium Sponsored by Bristol Myers Squibb: Thoracic Cancers, New Developments with IO
- 13:00 - 14:00
- 1/29/2021
- Location: Industry Symposia Auditorium (via Industry Hub)
- Not for CME Credit
- Type: Industry Symposium
- Track:
-
+
IS10.03 - IO in the Treatment of Metastatic NSCLC, Where Are We Now?
13:20 - 13:35 | Presenter: Julie Brahmer
- Abstract
No abstract available for this presentation
-
+
IS10.04 - Non-Metastatic and Metastatic NSCLC Q&A
13:35 - 13:40 | Presenter: Virginie Westeel, Julie Brahmer
- Abstract
No abstract available for this presentation
-
+
ES14 - Novel Immunotherapy Strategies in NSCLC
- 11:45 - 12:45
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
-
+
ES14.03 - Combining Epigenetic Therapy and Immunotherapy in NSCLC
11:57 - 12:09 | Presenter: Julie Brahmer
- Abstract
No abstract available for this presentation
-
+
IS11 - Industry Symposium Sponsored by Amgen Oncology: Advancing the Next Frontier of Innovation in Lung Cancer Therapies
- 13:00 - 14:00
- 1/30/2021
- Location: Industry Symposia Auditorium (via Industry Hub)
- Not for CME Credit
- Type: Industry Symposium
- Track:
-
+
IS11.04 - Emerging Novel Targets for Lung Cancer
13:40 - 14:00 | Presenter: Julie Brahmer
- Abstract
No abstract available for this presentation
-
+
MA07 - Improving Care for People with Lung Cancer: Decision Making, Survivorship, and New Challenges During COVID-19
- 15:30 - 16:30
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Patient Advocacy
-
+
MA07.05 - Survivors from Anti-PD-(L)1 Immunotherapy in NSCLC: Clinical Features, Survival Outcomes and Long-term Toxicities
15:50 - 15:55 | Presenter: Melinda Hsu
- Abstract
Loading...